Lavender Oil
drug drugOn this page
Also known as FEMA NO. 2622Lavandula angustifolia oilLavandulae aetheroleumLavender essential oil
Summary
Lavender Oil (CHEMBL2108210) is a phase-3 clinical-stage unknown (ATC N05BX05); indicated across 3 conditions including anxiety and neonatal abstinence syndrome.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- ATC class: N05BX05
- Indications: 3 conditions
- Clinical trials: 25
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2108210 |
| Name | Lavender Oil |
| Type | Unknown |
| Max phase | 3 |
| ATC | N05BX05 |
Also known as: FEMA NO. 2622, Lavandula angustifolia oil, Lavandulae aetheroleum, Lavender essential oil, Lavender oil, LAVENDER OIL
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
2 diseases in clinical trials (phase 1–3, investigational — not approved indications). Highest ChEMBL trial phase per disease; a non-cancer approved use is occasionally logged at phase 3 here.
| Disease (in trials) | Phase | MONDO | EFO |
|---|---|---|---|
| anxiety | 3 | MONDO:0011918 | EFO:0005230 |
| neonatal abstinence syndrome | 3 | MONDO:0005566 | EFO:0005799 |
1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 25.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 20 |
| PHASE1 | 2 |
| PHASE4 | 1 |
| PHASE3 | 1 |
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT06108648 | PHASE4 | RECRUITING | Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis |
| NCT03093454 | PHASE3 | COMPLETED | Effects of Lavender Oil on Postoperative Pain, Sleep Quality and Mood |
| NCT07315516 | PHASE2 | RECRUITING | Sleep and Stress Study |
| NCT05282706 | PHASE1 | ENROLLING_BY_INVITATION | Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting |
| NCT03090750 | PHASE1 | COMPLETED | Effects of Aromatherapy on Anxiety in Invasive Radiologic Procedure |
| NCT01837966 | Not specified | COMPLETED | Randomized, Placebo-Controlled Study: Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Patients |
| NCT03108781 | Not specified | UNKNOWN | The Role of Aromatherapy With Lavender Oil in the Long-term Care on a Patients Behavioral Problems Associated With Dementia |
| NCT03304938 | Not specified | COMPLETED | Lavender Aromatherapy on Sleep Quality and Metabolic Parameters of Type 2 Diabetic Patients With Insomnia |
| NCT03460626 | Not specified | COMPLETED | Evaluation of Aromatherapy on Academic Stress |
| NCT03857269 | Not specified | UNKNOWN | Acupoint Massage and Aromatherapy Intervention in Elderly People With Mild Cognitive Impairment in Nursing Institutions |
| NCT04257019 | Not specified | COMPLETED | Pain, Anxiety During Interventional Spine Procedures |
| NCT04648215 | Not specified | TERMINATED | Lavender Aromatherapy for Sleep in Hospitalized Adult Patients |
| NCT04666363 | Not specified | COMPLETED | Inhaled Lavender Applied at Hemodialysis Patients and Effect on Pain, Comfort, and Anxiety |
| NCT04822844 | Not specified | COMPLETED | Implementing a Nurse-Driven Aromatherapy Protocol to Decrease the Effect of Postoperative Nausea and Vomiting |
| NCT04848350 | Not specified | COMPLETED | Use of Inhaler Aromatherapy During SWL |
| NCT04877392 | Not specified | COMPLETED | Analgesic Effect of Inhaled Lavender Essential Oil for Clipping of Tongue-ties |
| NCT05500664 | Not specified | COMPLETED | The Effect of Aromatherapy on Anxiety in Patients |
| NCT05716711 | Not specified | COMPLETED | Essential Oils in Stoma Bags on Deodorization, Life Satisfaction, Stoma Adaptation in Individuals With Colostomy |
| NCT05728190 | Not specified | COMPLETED | Effect of Aromatherapy on Pain, Anxiety and Sleep Quality in Burn Patients |
| NCT05929638 | Not specified | UNKNOWN | Aromatherapy With Lavender Essential Oil in Patients With Multiple Sclerosis |
| NCT05988242 | Not specified | COMPLETED | Effect of Lavender Versus Primrose Oil on Menopause Symptom |
| NCT06066073 | Not specified | COMPLETED | Pain and Emotional Changes on Relationships Between Anxiety and Olfaction |
| NCT06167096 | Not specified | COMPLETED | Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery |
| NCT06581211 | Not specified | SUSPENDED | Aromatherapy Oil Associated for Managing Anxiety and Pain During Bone Marrow Biopsy Procedures |
| NCT07434323 | Not specified | COMPLETED | Lavender Aromatherapy for Preoperative Anxiety in Melanoma and Epithelioma Patients |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
- In clinical trials for: anxiety, neonatal abstinence syndrome